Isolation and partial characterisation of insulin-mimetic inositol phosphoglycans from human liver

被引:43
作者
Caro, HN
Kunjara, S
Rademacher, TW
Leon, Y
Jones, DR
Avila, MA
VarelaNieto, I
机构
[1] UNIV LONDON UNIV COLL, SCH MED, DEPT MOL PATHOL, MOL MED UNIT, LONDON W1P 6DB, ENGLAND
[2] CSIC, INST INVEST BIOMED, E-28029 MADRID, SPAIN
基金
英国医学研究理事会;
关键词
D O I
10.1006/bmme.1997.2607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracts of human liver were found to contain activities which copurified and coeluted with the two major subtypes of mediators (type A and type P) isolated from insulin-stimulated rat liver. The putative type A mediator from human liver inhibited cAMP-dependent protein kinase from bovine heart, decreased phosphoenolpyruvate carboxykinase mRNA levels in rat hepatoma cells, and stimulated lipogenesis in rat adipocytes. The putative type P mediator stimulated bovine heart pyruvate dehydrogenase phosphatase. Both fractions were able to stimulate proliferation of EGFR T17 fibroblasts and the type A was able to support growth in organotypic cultures of chicken embryo cochleovestibular ganglia. Both activities were resistant to Pronase treatment and the presence of carbohydrates, phosphate, and free-amino groups were confirmed in the two fractions. These properties are consistent with the structure/function characteristics of the type A and P inositol-phosphoglycans (IPG) previously characterized from rat liver. Further, the ability of the human-derived mediators to interact with rat adipocytes and bovine-derived metabolic enzymes suggests similarity in structure between the mediators purified from different species. Galactose oxidase-susceptible membrane-associated glycosylphosphatidylinositols (GPI) have been proposed to be the precursors of IPG. GPI was purified from human liver membranes followed by treatment with galactose oxidase and reduction with (NaBH4)-H-3. Serial t.l.c. revealed three radiolabeled bands which comigrated with the putative GPI precursors found in rat liver, These galactose-oxidase-reactive lipidic compounds, however, were only partially susceptible to hydrolysis with phosphatidylinositol-specific phospholipase C from Bacillus thuringiensis and were resistant to glycosylphosphatidylinositol-specific phospholipase C from Trypanosoma brucei. These data indicate that IPG molecules with insulin-like biological activities are present in human liver. (C) 1997 Academic Press.
引用
收藏
页码:214 / 228
页数:15
相关论文
共 60 条
[1]   TRANSPORT IN ISOLATED RAT HEPATOCYTES OF THE PHOSPHOOLIGOSACCHARIDE THAT MIMICS INSULIN ACTION - EFFECTS OF ADRENALECTOMY AND GLUCOCORTICOID TREATMENT [J].
ALVAREZ, JF ;
SANCHEZARIAS, JA ;
GUADANO, A ;
ESTEVEZ, F ;
VARELA, I ;
FELIU, JE ;
MATO, JM .
BIOCHEMICAL JOURNAL, 1991, 274 :369-374
[2]   INSULIN-LIKE EFFECTS OF INOSITOL PHOSPHATE-GLYCAN ON MESSENGER-RNA EXPRESSION IN RAT HEPATOCYTES [J].
ALVAREZ, L ;
AVILA, MA ;
MATO, JM ;
CASTANO, JG ;
VARELANIETO, I .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (08) :1062-1068
[3]   A PHOSPHATIDYLINOSITOL-LINKAGE-DEFICIENT T-CELL MUTANT CONTAINS INSULIN-SENSITIVE GLYCOSYL-PHOSPHATIDYLINOSITOL [J].
AVILA, MA ;
CLEMENTE, R ;
VARELANIETO, I .
BIOCHEMICAL JOURNAL, 1992, 282 :681-686
[4]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[5]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]   ROLE OF GLYCOSYL-PHOSPHATIDYLINOSITOL HYDROLYSIS AS A MITOGENIC SIGNAL FOR EPIDERMAL GROWTH-FACTOR [J].
CLEMENTE, R ;
JONES, DR ;
OCHOA, P ;
ROMERO, G ;
MATO, JM ;
VARELANIETO, I .
CELLULAR SIGNALLING, 1995, 7 (04) :411-421
[7]   DOES MITOGEN-ACTIVATED-PROTEIN KINASE HAVE A ROLE IN INSULIN ACTION - THE CASES FOR AND AGAINST [J].
DENTON, RM ;
TAVARE, JM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 227 (03) :597-611
[8]   INSULIN-INDUCED ACTIVATION OF GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE BY A CHIRO-INOSITOL-CONTAINING INSULIN MEDIATOR IS DEFECTIVE IN ADIPOCYTES OF INSULIN-RESISTANT, TYPE-II DIABETIC, GOTO-KAKIZAKI RATS [J].
FARESE, RV ;
STANDAERT, ML ;
YAMADA, K ;
HUANG, LC ;
ZHANG, C ;
COOPER, DR ;
WANG, Z ;
YANG, Y ;
SUZUKI, S ;
TOYOTA, T ;
LARNER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11040-11044
[9]  
Fonteles MC, 1996, DIABETOLOGIA, V39, P731
[10]   CIRCULATING FACTORS AND INSULIN-RESISTANCE .1. A NOVEL MYOINOSITOL 1,2-CYCLIC PHOSPHATE PHOSPHOGLYCAN INSULIN ANTAGONIST FROM HUMAN PLASMA IS ELEVATED IN NONINSULIN-DEPENDENT DIABETES-MELLITUS [J].
GALASKO, GTF ;
BAO, YD ;
BROOMFIELD, SJ ;
HOOPER, NM ;
TURNER, AJ ;
LARNER, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (08) :2419-2429